SFX by Ex Libris Inc.

Title:	Structural integration in hypoxia-inducible factors
Source:	Nature [0028-0836] Wu, D yr:2015

Basic

Full text

Full text available via Nature

Year:

Volume:

Issue:

Start Page:

Document delivery

Request document via Library/Bibliothek

Users interested in this article also expressed an interest in the following:
description	1.	Semenza, G. "Targeting HIF-1 for cancer therapy." Nature reviews. Cancer 3.10 (2003): 721-732.
description	2.	Freise, Kevin J J. "Modeling time variant distributions of cellular lifespans: increases in circulating reticulocyte lifespans following double phlebotomies in sheep." Journal of Pharmacokinetics and Pharmacodynamics 35.3 (2008): 285-323.
description	3.	Sullivan, Murray C. "bHLH–PAS proteins in cancer." Nature Reviews. Cancer 13.12 (2013): 827-841.
description	4.	Partch, Carrie L. "Coactivators necessary for transcriptional output of the hypoxia inducible factor, HIF, are directly recruited by ARNT PAS-B." Proceedings of the National Academy of Sciences of the United States of America 108.19 (2011): 7739-7744.
description	5.	MCDOWELL, R. "FROM PEPTIDE TO NONPEPTIDE .1. THE ELUCIDATION OF A BIOACTIVE CONFORMATION OF THE ARGININE-GLYCINE-ASPARTIC ACID RECOGNITION SEQUENCE." Journal of the American Chemical Society 116.12 (1994): 5069-5076.
description	6.	Harris, A. "Hypoxia - A key regulatory factor in tumour growth." Nature reviews. Cancer 2.1 (2002): 38-47.
description	7.	Semenza, G L. "Defining the role of hypoxia-inducible factor 1 in cancer biology and therapeutics." Oncogene 29.5 (2009): 625-634.
description	8.	Freise, Kevin J J. "Pharmacodynamic modeling of the effect of changes in the environment on cellular lifespan and cellular response." Journal of Pharmacokinetics and Pharmacodynamics 35.5 (2008): 527-52.
description	9.	Melillo, G. "Inhibiting hypoxia-inducible factor 1 for cancer therapy." Molecular cancer research 4.9 (2006): 601-605.
description	10.	Kerbel, R. "Clinical translation of angiogenesis inhibitors." Nature reviews. Cancer 2.10 (2002): 727-739.
description	11.	Cheng, J. "Formulation of functionalized PLGA-PEG nanoparticles for in vivo targeted drug delivery." Biomaterials 28.5 (2006): 869-876.
description	12.	Ming Yan, M. "The tumor suppressor folliculin regulates AMPK-dependent metabolic transformation." The Journal of clinical investigation 124.6 (2014): 2640-2650.
description	13.	Shamloo, M. "Npas4, a novel helix–loop–helix PAS domain protein, is regulated in response to cerebral ischemia." European journal of neuroscience 24.10 (2006): 2705-2720.
description	14.	Altun, M. "Ubiquitin-specific protease 19 (USP19) regulates hypoxia-inducible factor 1α (HIF-1α) during hypoxia." Journal of biological chemistry 287.3 (2012): 1962-1969.
description	15.	Dyson, H. Jane e. "Expanding the proteome: disordered and alternatively folded proteins." Quarterly reviews of biophysics 44.4 (2011): 467-518.
description	16.	Heikkil, M. "Roles of the human hypoxia-inducible factor (HIF)-3α variants in the hypoxia response." Cellular and molecular life sciences 68.23 (2011): 3885-3901.
description	17.	Henry, Jonathan T. "Ligand-Binding PAS Domains in a Genomic, Cellular, and Structural Context." Annual review of microbiology 65.1 (2011): 261-286.
description	18.	Card, Paul B. "Structural basis of ARNT PAS-B dimerization: use of a common beta-sheet interface for hetero- and homodimerization." Journal of molecular biology 353.3 (2005): 664-677.
description	19.	Michaud, J L L. "Development of neuroendocrine lineages requires the bHLH-PAS transcription factor SIM1." Genes & development 12.20 (1998): 3264-3275.
description	20.	Shannon, H E E. "Development and validation of the maximal electro-shock seizure model in dogs." Journal of veterinary pharmacology and therapeutics 30.6 (2007): 508-15.